Progress and challenges in Nipah vaccine development and licensure for epidemic preparedness and response

This is the authors' abstract. We don't add key points for this paper.

We recommend alignment among vaccine developers, regulators, and global health stakeholders to incentivize Nipah vaccine development and approval through alternative regulatory pathways, as well as ensuring epidemic preparedness via strategic vaccine stockpiling and response through targeted deployment strategies.